Advertisement
CI vs CVS
Which Stock Would AI Choose? Cigna (CI) vs. CVS Health (CVS) Stock Comparison
Key Takeaways
- CI (Cigna) trades near $290 with modest year-to-date gains of approximately 4-5% and recent monthly declines of 1-2%, while awaiting its Q2 2026 earnings release on July 30.
- CVS (CVS Health) trades near $104 with stronger year-to-date gains of 31-34% and monthly advances of 4-7.5%, following raised full-year 2026 guidance after solid Q1 results.
- Cigna operates as a global health services provider through Cigna Healthcare and Evernorth Health Services, serving over 185 million customer relationships with emphasis on insurance and pharmacy benefit management.
- CVS Health integrates pharmacy retail, benefits management, and health services across thousands of locations, benefiting from revenue growth and operational turnaround initiatives.
- Recent market activity shows CVS delivering superior relative performance compared to CI, driven by guidance increases and sector positioning.
- Both stocks face healthcare sector dynamics including regulatory pressures and reimbursement trends, with differing momentum profiles influencing current sentiment.
Introduction
The comparison of CI and CVS provides traders and investors with insights into two established players in the diversified healthcare sector. Cigna focuses primarily on health insurance and benefits management, while CVS Health combines pharmacy services, retail operations, and care delivery. This analysis examines recent price behavior, business models, and market positioning to assist those evaluating relative performance in the current environment. Portfolio managers, sector specialists, and active traders monitoring healthcare equities may find the side-by-side review relevant for assessing momentum and risk factors.
CI Overview and Recent Performance
The Cigna Group delivers health benefits and services through its Cigna Healthcare and Evernorth Health Services segments. The company serves a broad customer base across insurance and pharmacy solutions. In recent market activity, the stock has traded near $290 levels following a period of modest year-to-date appreciation. Performance in recent weeks reflected mixed sentiment, with monthly declines of roughly 1-2% amid broader index adjustments and anticipation of the upcoming Q2 2026 earnings release scheduled for July 30. Developments such as an AI initiative in specialty pharmacy and changes in index inclusion have contributed to ongoing investor focus on operational efficiency and profitability trends.
CVS Overview and Recent Performance
CVS Health operates an integrated model encompassing retail pharmacies, pharmacy benefit management, and health services. The company maintains an extensive network of locations and supports large-scale prescription fulfillment. Recent market activity has shown stronger momentum, with the stock advancing to the $104 area and posting year-to-date gains exceeding 30%. Over recent weeks, monthly performance improved by approximately 4-7.5%, supported by Q1 2026 revenue growth and an upward revision to full-year 2026 guidance. Focus on community investments and efforts to stabilize segments have helped shape positive sentiment relative to prior periods.
Trending AI Robots
Tickeron’s Trending AI Robots page curates top-performing AI trading bots from a library of hundreds that actively trade thousands of tickers across global markets. Only those demonstrating the strongest alignment with prevailing conditions, including consistent win rates, risk-adjusted returns, and adaptability across strategies, earn placement in this section. Available bots span diverse styles such as trend-following, mean-reversion, and momentum approaches, with varying timeframes from intraday to multi-week horizons and performance statistics that include win rates, profit factors, and drawdown metrics. Investors exploring automated strategies for equities like CI and CVS can review the curated selection for data-driven insights.
Head-to-Head Comparison
Cigna and CVS Health both participate in healthcare services yet differ in business emphasis. Cigna centers on insurance underwriting and benefits administration, exposing it to medical loss ratios and regulatory changes in coverage. CVS Health integrates retail pharmacy scale with benefits management, benefiting from volume-driven revenue and direct consumer access. Recent momentum favors CVS Health, which posted larger year-to-date and monthly gains compared to Cigna’s more contained movement. Risk factors include reimbursement pressures for both, though CVS Health’s diversified locations may provide additional buffers. Market sentiment has reflected CVS Health’s guidance updates more favorably in recent activity, while Cigna’s positioning highlights steadier long-term targets amid index-related developments. Trade-offs center on growth visibility versus operational stability within the sector.
Tickeron AI Verdict
Based on observable factors including relative price momentum, consistency of recent advances, and positioning around earnings catalysts, Tickeron’s AI analysis indicates a probabilistic preference for CVS in the current environment. Stronger year-to-date performance and guidance revisions provide measurable support compared to the more measured trajectory observed for CI. This assessment remains data-dependent and subject to shifts in trend consistency or new developments.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CI is a Buy and CVS is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CI’s FA Score shows that 1 FA rating(s) are green whileCVS’s FA Score has 3 green FA rating(s).
- CI’s FA Score: 1 green, 4 red.
- CVS’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CI’s TA Score shows that 6 TA indicator(s) are bullish while CVS’s TA Score has 3 bullish TA indicator(s).
- CI’s TA Score: 6 bullish, 5 bearish.
- CVS’s TA Score: 3 bullish, 5 bearish.
Price Growth
CI (@Managed Health Care) experienced а +7.99% price change this week, while CVS (@Managed Health Care) price change was +3.74% for the same time period.
The average weekly price growth across all stocks in the @Managed Health Care industry was +0.83%. For the same industry, the average monthly price growth was +7.45%, and the average quarterly price growth was +35.30%.
Reported Earning Dates
CI is expected to report earnings on Jul 30, 2026.
CVS is expected to report earnings on Aug 05, 2026.
Industries' Descriptions
@Managed Health Care (+0.83% weekly)Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
| CI | CVS | CI / CVS | |
| Capitalization | 80.6B | 135B | 60% |
| EBITDA | 12.1B | 11.1B | 109% |
| Gain YTD | 11.889 | 35.721 | 33% |
| P/E Ratio | 12.91 | 46.45 | 28% |
| Revenue | 268B | 408B | 66% |
| Total Cash | 7.8B | 11.8B | 66% |
| Total Debt | 30.9B | 78.3B | 39% |
CI | CVS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 28 | 75 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 5 Undervalued | 4 Undervalued | |
PROFIT vs RISK RATING 1..100 | 58 | 64 | |
SMR RATING 1..100 | 56 | 88 | |
PRICE GROWTH RATING 1..100 | 51 | 7 | |
P/E GROWTH RATING 1..100 | 76 | 5 | |
SEASONALITY SCORE 1..100 | 47 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CVS's Valuation (4) in the Drugstore Chains industry is in the same range as CI (5) in the Managed Health Care industry. This means that CVS’s stock grew similarly to CI’s over the last 12 months.
CI's Profit vs Risk Rating (58) in the Managed Health Care industry is in the same range as CVS (64) in the Drugstore Chains industry. This means that CI’s stock grew similarly to CVS’s over the last 12 months.
CI's SMR Rating (56) in the Managed Health Care industry is in the same range as CVS (88) in the Drugstore Chains industry. This means that CI’s stock grew similarly to CVS’s over the last 12 months.
CVS's Price Growth Rating (7) in the Drugstore Chains industry is somewhat better than the same rating for CI (51) in the Managed Health Care industry. This means that CVS’s stock grew somewhat faster than CI’s over the last 12 months.
CVS's P/E Growth Rating (5) in the Drugstore Chains industry is significantly better than the same rating for CI (76) in the Managed Health Care industry. This means that CVS’s stock grew significantly faster than CI’s over the last 12 months.
| CI | CVS | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 75% | 1 day ago 61% |
| Stochastic ODDS (%) | 1 day ago 61% | 1 day ago 65% |
| Momentum ODDS (%) | 1 day ago 65% | 1 day ago 71% |
| MACD ODDS (%) | 1 day ago 50% | 1 day ago 54% |
| TrendWeek ODDS (%) | 1 day ago 60% | 1 day ago 63% |
| TrendMonth ODDS (%) | 1 day ago 62% | 1 day ago 61% |
| Advances ODDS (%) | 1 day ago 63% | 1 day ago 67% |
| Declines ODDS (%) | 14 days ago 55% | 8 days ago 58% |
| BollingerBands ODDS (%) | 1 day ago 80% | 1 day ago 71% |
| Aroon ODDS (%) | 1 day ago 77% | 1 day ago 70% |
Advertisement
CI and
Correlation & Price change
A.I.dvisor indicates that over the last year, CI has been loosely correlated with CVS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CI jumps, then CVS could also see price increases.
CVS and
Correlation & Price change
A.I.dvisor indicates that over the last year, CVS has been loosely correlated with UNH. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if CVS jumps, then UNH could also see price increases.